Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mirus Securities is a U.S. registered broker-dealer and investment banking entity affiliated with Mirus Capital Advisors. The firm appears to support middle-market M&A, capital advisory, valuation, and related corporate finance transactions rather than developing therapeutics, diagnostics, or healthcare products. Although Mirus Capital Advisors has a healthcare and life sciences advisory practice, Mirus Securities itself is not a biotech, pharma, or healthcare operating company. It should be classified as a financial services firm serving multiple industries, including healthcare and life sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mirus Securities.